AMINOSYN II 7% W/ ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
NDAINJECTIONINJECTABLE
Approved
Apr 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 10h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN II 7% w/ Electrolytes is a parenteral nutrition solution containing amino acids, magnesium chloride, potassium chloride, potassium phosphate, and sodium chloride delivered via injection. It is indicated for patients requiring intravenous nutritional support, particularly those unable to maintain adequate nutrition orally or enterally. The formulation provides essential amino acids and electrolytes to support protein synthesis and maintain electrolyte balance.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%), indicating shrinking team focus and limited career growth opportunity on this brand.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN II offers limited career growth given the product's mature lifecycle and approaching loss of exclusivity. Roles are primarily focused on operational efficiency, regulatory maintenance, and hospital distribution rather than innovation or strategic expansion.
Supply Chain ManagerRegulatory Affairs Specialist
Worked on AMINOSYN II 7% W/ ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.